# SOFIE Co. dba SOFIE – FDA Inspection, Apr 21, 2026

Source: https://www.keypedia.com/records/fda_inspections/sofie-co-dba-sofie/9f97f7aa-21b4-490d-9d7d-a4ffd9f3575a
Source feed: FDA_Inspections

> FDA inspection 1313566 of SOFIE Co. dba SOFIE, April 21, 2026. 1 citation under 21 CFR part 212. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1313566
- Company Name: SOFIE Co. dba SOFIE
- Inspection Date: 2026-04-21
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Dallas District Office
- Citation Count: 1

## Related Documents

- [FDA Inspection 1076429 - 2019-01-15](https://www.keypedia.com/records/fda_inspections/sofie-co-dba-sofie/626cbb81-7f76-4192-b370-00ee7bd5a150)
- FDA Inspection 970671 - 2016-05-27
- FDA Inspection 854064 - 2013-10-22

## Related Officers

- [Youkeun Kim](https://www.keypedia.com/people/youkeun-kim/94ccfde4-72f7-4df1-9c68-ede73e5e23d0)

Company: https://www.keypedia.com/companies/sofie-co-dba-sofie/3b677367-baec-43c5-8387-5939b730d8b7

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9